Discounted Cash Flow (DCF) Analysis Levered

Allscripts Healthcare Solutions, In... (MDRX)

$7.6

-0.71 (-8.54%)
All numbers are in Millions, Currency in USD

Free Cash Flow

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 1,7501,771.701,502.701,5031,433.241,366.731,303.301,242.811,185.131,130.13
Revenue (%)
Operating Cash Flow 67.9046.30-106.72-75.40-20.15-19.22-18.33-17.48-16.67-15.89
Operating Cash Flow (%)
Capital Expenditure -144.60-130.50-105.02-78.60-99.78-95.15-90.73-86.52-82.51-78.68
Capital Expenditure (%)
Free Cash Flow -76.70-84.20-211.73-154-119.93-114.37-109.06-104-99.17-94.57

Weighted Average Cost Of Capital

Share price $ 7.6
Beta 0.699
Diluted Shares Outstanding -
Cost of Debt
Tax Rate -659.17
After-tax Cost of Debt 5.00%
Risk-Free Rate
Market Risk Premium
Cost of Equity 7.621
Total Debt -
Total Equity -
Total Capital -
Debt Weighting -
Equity Weighting -
Wacc

Build Up Free Cash Flow

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 1,7501,771.701,502.701,5031,433.241,366.731,303.301,242.811,185.131,130.13
Operating Cash Flow 67.9046.30-106.72-75.40-20.15-19.22-18.33-17.48-16.67-15.89
Capital Expenditure -144.60-130.50-105.02-78.60-99.78-95.15-90.73-86.52-82.51-78.68
Free Cash Flow -76.70-84.20-211.73-154-119.93-114.37-109.06-104-99.17-94.57
WACC
PV LFCF -119.93-----
SUM PV LFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) -
Free cash flow (t + 1) -95.51
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -
Equity Value -
Shares Outstanding -
Equity Value Per Share -